StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD)

Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report issued on Saturday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Stock Down 1.4 %

Shares of NASDAQ:AEMD opened at $0.67 on Friday. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.10. The firm’s 50-day simple moving average is $0.50 and its 200-day simple moving average is $0.43. The company has a market cap of $9.31 million, a price-to-earnings ratio of -0.24 and a beta of 1.61.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.